Anti-CD28 antibody
US7723482B2 · kind B2 · utility
17Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2001 |
| Grant date | May 25, 2010 |
| Priority date | — |
| Expiry date | Nov 14, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antibody or antibody fragment directed against the CD28 receptor which blocks the interaction between B7-1 or B7-2 and CD28. Methods for blocking activation via CD28, including CD28-dependent lymphocyte activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.